News

July 10, 2015 10:30 am
Having myeloma is undeniably expensive. But will new systems of evaluating the cost and efficacy of treatment end up harming myeloma patients by mandating suboptimal care and eliminating access to needed drugs? In his blog this week, IMF Chairman...
July 10, 2015 10:30 am
Dr. Ola Landgren announced the opening of a new Phase I/II clinical trial at Memorial Sloan-Kettering Cancer Center for patients with relapsed and/or refractory myeloma. The trial will test a new proteasome inhibitor called VLX1570, which is given...
June 28, 2015 10:30 am
The IMF will host a two-day Patient & Family Seminar August 21-22 at the Sheraton Universal Hotel in Los Angeles, California. What do you get at an IMF Patient & Family Seminar? Attendees will receive the latest information on myeloma,...
June 28, 2015 10:30 am
Myeloma patients need to have access to their medical records. But gathering years of data from dozens of different providers can be a challenge. At this summer’s annual Support Group Leader Summit, the IMF will present an educational session...

Pages